This paper proposes a new set of public health and long-term
Introduction
Spending on health and long-term care (henceforth LTC) is a first-order policy issue for most governments in OECD countries. These expenditures are putting pressure on public budgets, adding to that arising from other social spending programmes and, once interest rates normalise, servicing of higher debt levels than in the past. The ratio of public health and LTC expenditure to GDP 1 has been rising steadily for several decades. Since 1970, on average across OECD countries, the expenditure to GDP ratio has increased by 3.5 percentage points to reach around 7 percentage points in 2010. Interestingly, this ratio tends to increase during recession periods meaning that health expenditure keeps on rising while GDP stagnates or decreases (Figure 1 ). Despite a recent slowdown, as a share of GDP, public health and long-term care expenditure have still increased by slightly less than 1 percentage point from the level prior to the crisis.
Looking towards the future, the OECD (2006) public health and LTC spending projections highlighted the growing pressures over the next 50 years. In an upside "costpressure" scenario, average health and LTC expenditure was projected to almost double again, to reach approximately 13% of GDP by 2050. But, even in the so-called "cost- 1 9 7 2 1 9 7 4 1 9 7 6 1 9 7 8 1 9 8 0 1 9 8 2 1 9 8 4 1 9 8 6 1 9 8 8 1 9 9 0 1 9 9 2 1 9 9 4 1 9 9 6 1 9 9 8 2 0 0 0 2 0 0 2 2 0 0 4 2 0 0 6 2 0 0 8 2 0 1 0
The projections in this paper update and refine the OECD (2006) analysis by extending the country coverage and improving the method of estimating future developments in health and LTC expenditure. In addition to the 34 OECD countries, health and LTC expenditure is also projected for Brazil, China, India, Indonesia, Russia and South Africa (henceforth BRIICS). Concerning the methodology, as in 2006, the new projections separate health and LTC and, within each type of expenditure, demographic from non-demographic drivers. For health care, the main difference concerns the non-demographic drivers, with an attempt to better understand the residual expenditure growth by determining which share can be explained by the evolution of health prices and technology effects. Regarding LTC, a more precise estimation of the determinants of the number of dependants (people needing help in their daily life activities) is provided. In particular, the current set of projections treats health expenditure itself as a determinant of the dependency ratios 12.0 2 0 0 0 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 0 0 1 2 0 0 2 2 0 0 3 2 0 0 4 2 0 0 5 2 0 0 6 2 0 0 7 2 0 0 8 2 0 0 9 2 0 1 0 OECD average 2006 cost-containment scenario 2006 cost-pressure scenario
A. Comparison of actual development and OECD (2006) projections
In % of trend GDP 2 B. Share of health and LTC spending in total public spending In % of total public expenditure (number of dependent people in total population) by age groups. Finally, the new projections extend to 2060.
The projections are provided for public expenditure only. Nonetheless, the crosscountry differences in treatment of tax expenditures, 2 which can be large in some cases, may introduce serious bias in the split between public and private expenditures. Indeed, countries interpret differently the OECD manual on the System of Health accounts on how to deal with tax expenditures. Australia and Germany, for instance, deduct tax expenditures from private insurance expenditures and report it as public expenditure. But, in the United
States, tax expenditures are not considered as public expenditure (OECD, 2010) .
The paper is set out as follows. In Section 2, the main demographic and nondemographic drivers of public health expenditure are analysed and projected over the next half century. Cost-containment (with implicit policy actions) and cost-pressure (without policy actions) scenarios are presented, followed by a discussion of the sensitivity of the results to key assumptions. In Section 3, the same sequence applies to public LTC expenditures. In Section 4, different health and LTC expenditure scenarios are combined in order to provide a range of estimates for total expenditure. Section 5 concludes.
Health care

The determinants of public health care expenditure
The drivers of public health care expenditure are demographic and non-demographic ( Figure 3 ). Demographic drivers relate broadly to the age structure of the population and the evolution of its health status, while a non-demographic driver is income. The relationship between health expenditures and income remains an unsettled issue, but independent of the precise income elasticity (measure of the responsiveness of health expenditure to a change in income) the combination of demographic and income effects fails to explain a large part of the total growth in public health-care expenditure in the past.
Thus, a residual unexplained growth remains. Relative prices, technological progress and the underlying health policies and institutions are the most likely candidates for explaining this residual (see Box 3 in de la Maisonneuve and Oliveira Martins, 2013) .
To quantify the relative contribution of each driver over the past 15 years, a simple accounting analysis was carried out (for data sources and methodology, see Annex A). The analysis accounts for changes in the population structure during the period 1995-2009, and assumes an income elasticity of health spending of either 0.8 or 1 (see below for a discussion of this hypothesis). Based on these assumptions an expenditure residual was derived. As can be seen from Table 1 , demographic drivers explain relatively little of past 
Projection framework
The framework used to project public health expenditure combines both the demographic and non-demographic drivers described above. The evolution of each driver is first projected separately, and subsequently combined to compute the future growth of total health expenditure. Thus, the evolution of the future share of public health care spending in GDP depends on demographic and real income per capita projections, as well as on the extrapolated residual growth component. The demographic driver includes three elements -death-related costs, pure age effects based on population projections drawn from different sources and a healthy-ageing effect -which are described below. Future GDP is based on projections published in the OECD Economic Outlook, No. 91. 3 As in the historical N e w Z e a l a n d I n d o n e s i a C h i l e T u r k e y I r e l a n d N e t h e r l a n d s C h i n a B r a z i l U n i t e d K i n g d o m D e n m a r k B e l g i u m P o l a n d G r e e c e B R I I C S a v e r a g e 1 P o r t u g a l U n i t e d S t a t e s S l o v a k R e p u b l i c I t a l y N o r w a y I n d i a O E C D a v e r a g e 1 A u s t r a l i a E s t o n i a S w i t z e r l a n d F i n l a n d A u s t r i a S w e d e n S p a i n C z e c h R e p u b l i c S o u t h A f r i c a M e x i c o I c e l a n d C a n a d a J a p a n F r a n c e G e r m a n y S l o v e n i a R u s s i a n F e d e r a t i o n L u x e m b o u r g H u n g a r y I s r a e l accounting exercise, the income effects are captured by an elasticity of health expenditures that can take the value of 0.8 or 1, depending on the scenario.
The growth rates in spending ratios are first projected for each country and they are then adjusted to allow for a certain convergence across countries towards a common target level. Ceteris paribus, countries having a below-average initial level of public health expenditure to GDP ratios are projected to experience higher growth rates than those close to the average. This makes the projections more comparable across countries, as the effects of the different mechanisms at work during the projection period are isolated from the impact of the initial conditions. This is particularly important in the context of a projection method that does not assume country-specific residual growth in expenditures (as in the baseline assumed in this paper), or for countries that have in the base year a very low level of spending, such as emerging economies.
Therefore, the projected (for period t) health spending ratios were adjusted as follows:
where g i is the growth rate of health spending for country i (from period 0 to period t);
is the health expenditure ratio for country i in the base period; and is the health expenditure ratio for the OECD average in the base period.
When the spending ratio of a given country is below (or above) the OECD average for the base year this adjustment will increase (decrease) the projected growth rate of expenditures to GDP, thus allowing for convergence to take place. In order to smooth out the impact of the recent crisis on expenditure, the base year spending ratios are computed as the average shares of public health care spending in GDP over 2006-10. This framework is used to project public health care expenditures over the period 2010-60.
The base information used to construct the health expenditure projection framework is the average health expenditure profile by age group ( Figure 5 ). Average health 10   0   2  7  12  17  22  27  32  37  42  47  52  57  62  67  72  77  82  87  92  97  Age (middle of 5-years age brackets) % of GDP per capita expenditures are relatively high for young children; they decrease and remain stable for most of the prime-age period, and then start to increase rapidly in older age, the health care cost of people aged 90 and over being six times that of young people. Until the age of 65, health expenditure profiles are rather similar across countries, but from 65 onwards, they display a large heterogeneity. The standard deviation by age group increases from 1.8% for the 65-69 age group to more than 5% for people aged 90 and over.
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From Figure 5 , it could be expected a priori that an ageing population would be associated with increasing aggregate per capita public health care expenditures: the fact that the share of older people in the population is growing faster than that of any other age group, both as a result of longer lives and a lower birth rate, should generate an automatic increase in the average. However, this intuition finds little support in the data and assessing the effect of population ageing on health and health care has proved to be far from straightforward (Breyer et al., 2011) .
Consistent with a large number of previous studies (Felder et al., 2000; Seshamani and Gray, 2004; Breyer and Felder, 2006; and Werblow et al., 2007; etc.) , this paper assumes that what matters for health spending is not ageing but rather the proximity to death, i.e. the so-called "death-related costs" (DRC) hypothesis. This interpretation is consistent with the observed facts that health-care expenditure tends to increase in a disproportionate way when individuals are close to death, and mortality rates are obviously higher for older people. When the projected increase in life expectancy is accompanied by an equivalent gain in the number of years spent in good health, the health care spending is only driven by the proximity to death and not by an increase in the average age of the population. In other words, it is not ageing per se that pushes up average health expenditures, but rather the fact that mortality rates increase with age. The death-related costs hypothesis is, therefore, consistent with a so-called healthy-ageing regime, where longevity gains are all translated into years in good health (Box 1).
Box 1. Healthy ageing hypothesis
To take into account the "healthy ageing" hypothesis, the survivor expenditure curve is allowed to shift rightwards according to longevity gains, progressively postponing the agerelated increases in expenditure. First, the curve by five-year age groups is interpolated in order to derive a yearly age profile. In this way, the expenditure curve can be shifted smoothly over time, in line with life expectancy gains.
Subsequently, the shift of the curve can be simulated by subtracting the increase in life expectancy at birth according to national projections from each current age. For example, a 70-year old person in Germany is projected to have the health status of a 67-year old person by 2025 and that of a 64-year old person by 2050.
By contrast, in a "pure demographic" scenario, the expenditure curves would not shift rightwards with ageing, reflecting the implicit assumption of unchanged health status at any given age. When these curves stay put in the presence of longevity gains, the share of life lived in "bad health" increases with life expectancy.
It should be noted that the population projections used in the analysis are predetermined and do not take into account the effect of health spending on health status and longevity. Making population projections dependent on the level of health spending is beyond the scope of this project and could be the object of further research.
To account for the dominance of death-related costs and the healthy-ageing regime, the expenditure curve by age group needs to be split for each period into two segments of the population: survivors and non-survivors. The non-survivors' expenditure curve can be estimated by multiplying the estimated health costs in the proximity to death by age group by the number of deaths per age group. The "cost of death" was proxied here by the health expenditure per capita for the oldest age group (95+) multiplied by a factor that captures the tendency for the costs of death to be higher at younger ages. This factor is kept constant at 4 for people aged between 0 and 59 years and declines linearly (towards unity) afterwards. 4 As regards non-survivors, two different demographic effects are at play. On the one hand, the number of deaths is set to rise due to the transitory effect of the post-War babyboom. On the other hand, if mortality falls over time due to an ongoing increase in longevity, fewer will be at the very end of life in each given year, thus mitigating health care costs. 5 The impact of demographic developments on public health care expenditures will depend on the relative size of these effects.
In principle, the survivors' expenditure curve for each country could be derived from the difference between the total cost curve and that of the non-survivor. However, given the uncertainties surrounding these data, it seemed preferable to estimate an average expenditure curve for survivors, to be then used for all countries. In this way, the projections are less sensitive to initial conditions and to country-specific data idiosyncrasies. This expenditure curve for survivors was estimated econometrically as a non-linear function of age. Each country-specific curve is then calibrated in order to fit the base year of the projections.
Non-demographic drivers
As mentioned above, overall demographic drivers explain relatively little of past developments in health spending, even assuming that the expenditure curve by age remains constant (or abstracting from "healthy ageing" effects). Therefore, the nondemographic drivers must play an important role: these are the growth in income and a residual growth component.
The effect of real income growth on public health expenditures has been the subject of a vast debate, but the precise value of the income elasticity is still uncertain. Empirical estimates tend to increase with the degree of income aggregation, implying that health care could be "an individual necessity and a national luxury" (Getzen, 2000) . However, a high aggregate income elasticity (above unity) often found in macro studies may result from biases in estimates originating from a number of sources, such as failure to appropriately control for quality effects and account for the peculiar statistical properties of some of the variables. Based on the most recent findings from this literature (e.g. Acemoglu et al., 2009; and Holly et al., 2011) , as well as estimations carried out by the authors, a real income elasticity equal to 0.8 has been used (a middle point across those estimates) and the sensitivity of the projections to this assumption was subsequently tested (by contrast, OECD, 2006 assumed a unitary income elasticity throughout).
Once income growth has been accounted for, several factors may explain the residual growth observed in the past: developments in relative prices, technological progress and the features of health institutions and policies (see Box 3 and Appendix 2 in de la Maisonneuve and Oliveira Martins, 2013). It is not feasible at this stage to project these drivers individually.
Nonetheless, in an attempt to interpret this residual growth, an econometric equation has been estimated, incorporating explicitly the effects of prices and a proxy for quality.
Accordingly, the income elasticity (), as well as the price () and quality () elasticities, were derived from a panel regression (in log terms and expressed in quality-adjusted health volumes per capita), augmented with the drift factors related to demography and exogenous policy factors captured by a time trend (e.g. institutional reforms increasing the coverage of the health coverage system):
where he denotes health care demand volumes (deflated for price and quality), N is total population, Age is the average age of the population, P are health care prices, P Y is the GDP factor, Q is a quality index for health care products and Y is real GDP; α c correspond to country fixed-effects; T to a time trend; and u a randomly distributed residual. The equation was estimated both in levels and in first differences. The demographic effect is captured by the average age of the population. The quality effect (Q) was loosely proxied by a ratio involving the relative pace of patent creation in the health sector compared with the rest of the economy for the average of OECD countries. This ratio is assumed to represent the change in the technology frontier. To capture country-specific effects related to the diffusion and adoption of technology, the ratio is multiplied by the share of R&D expenditures in GDP.
The results of the econometric estimation are relatively robust, with the value of the income elasticity fluctuating from around 0.5 to close to 1, depending on the specifications. The preferred econometric estimate (column 8 of Table 2 ) gives an estimated elasticity of 0.42 for relative prices (β) and 0.91 for the technology/quality effect (γ). Translating these into expenditure elasticities, (β + 1) and (1 -γ), and the observed growth rates of (P/P Y ) and (Q) the overall effect of technology and relative prices is estimated to have increased health-care expenditures by 0.8% per year. In other words, the econometric model is able to explain more than one-third of the past expenditure residual of 2% per year for the OECD average, displayed in Table 1 . Estimates suggest that the residual expenditure is also driven by other factors, such as changes in policy and institutions which can be loosely captured by a time trend. These other factors account for 0.9% of the increase in health expenditure per year. Overall, these estimates suggest that the residual expenditure has increased health-care expenditures by around 1.7%
(i.e. 0.8% + 0.9%) per year.
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As stated previously, a common residual growth is assumed for all countries in order not to extrapolate country-specific idiosyncrasies over a long period. Based on the estimates of Table 2 , the projections assume a uniform residual expenditure growth of 1.7% per year.
Summing up
To summarise graphically the way in which demographic and non-demographic drivers contribute to health care spending (Figure 6 ), the mechanical effect of population ageing on expenditures can be displayed as moving up along the expenditure curve, assuming that the age profile of expenditures remains constant over time (Panel 1). This age factor is then adjusted by incorporating the healthy ageing hypothesis, corresponding to a rightward shift of the curve (Panel 2). This shift implies that older people still cost more than the young, but at progressively older ages. Finally, the expenditure curve may shift upwards 7 (Panel 3) due to non-demographic drivers (income, the quality-adjusted relative health prices and other unexplained factors, such as policies and institutions).
Projection results: Public health expenditures, 2010-2060
This section applies the analytical framework to project public health care expenditures in different scenarios over 2010-60. The main assumptions underlying each scenario are listed in Table 3 . The section looks first at the demographic and income effects on expenditures and, subsequently, two scenarios regarding the evolution of drivers other than income and demographics (i.e. the residual growth) are analysed. In the "cost pressure scenario" no policy action is undertaken to curb pressures on expenditure whereas the "cost-containment scenario" assumes some policy action to rein in these pressures on expenditures. Even though the nature of such policies is not made explicit, they can be thought of as actions to limit the pressures arising from excessive growth of quality-adjusted relative health prices, e.g. by monitoring more closely the adoption of new technologies or modifying incentives via changes in the governance of health institutions. Standard errors in parentheses. * = p < 0.10; ** = p < 0.05; *** = p < 0.01. Note: Projections are based on the estimates highlighted within the box.
All these scenarios assume healthy ageing and an income elasticity of 0.8. Finally, sensitivity analysis is carried out in the context of the cost-containment scenario. More specifically, sensitivity analysis is carried out regarding the value of the income elasticity, the evolution of residual spending growth (i.e. unrelated to income and demographics) and the "healthy ageing" hypothesis. Concerning the latter, results are obtained also in the case of no healthy ageing (i.e. morbidity expands with gains in longevity) and for a more optimistic hypothesis under which each year increase in life expectancy is translated into two years spent in good health. 
Demographic and income effects
As discussed above, demographic effects on public health care expenditures can be decomposed into health care costs for survivors, the adjustment for "healthy ageing" and death-related costs. The pure ageing effect can be quite large in some countries, but tends to be compensated by better health status. Whereas on a per capita basis death-related costs account for the largest part of lifetime expenditures, for the population as a whole they account for only a small fraction of the increase in expenditures as a share of GDP since they concern only the non-survivors.
On average, the demographic effect only accounts for a small increase in expenditure.
In OECD countries and on its own, it pushes spending from 5.5% of GDP on average to 6.2% in 2060. In non-OECD countries, the demographic effect on its own increases spending from 2.4% of GDP to 3.4% in 2060. While the "healthy ageing" assumption may render the simulation of demographic effects relatively optimistic, this is in line with observed patterns of health status regimes in many OECD countries. It is assumed that the same pattern will apply to non-OECD countries. The effect is projected to apply evenly before and after 2030 for both OECD and non-OECD countries.
It is noteworthy that while demography is not a main driver of health care spending growth, it will induce a significant change in the structure of spending over time. In 2010, 60% of health care expenditures were directed to people below 65 years old. In 2060, roughly the same percentage of expenditures will be directed to people aged above 65, reflecting an increase from 15% to 30% of their share in total population ( Figure 7 ). This evolution is only the consequence of demographic effects as non-demographic effects are n.a. n.a.
Cost-pressure scenario Healthy ageing: Longevity gains are translated into equivalent additional years in good health.
Income elasticity = 0.8 The residual is assumed to grow at 1.7% over the projection period.
Cost-containment scenario
Healthy ageing: Longevity gains are translated into equivalent additional years in good health.
Income elasticity = 0.8 The residual growth is 1.7% in the starting period and then converges to 0 in 2060.
Sensitivity analysis based on the cost-containment scenario
Compression of morbidity Longevity gains are doubled into additional years in good health.
Expansion of morbidity
No healthy ageing adjustment, i.e. longevity gains do not translate into additional years in good health.
Income elasticity = 0.8
The residual growth is 1.7% in the starting period and then converges to 0 in 2060.
Country-specific quality adjusted relative prices
Income elasticity = 0.8 The residual growth is country specific and converges to 0 in 2060.
Income elasticity = 0.6 Healthy ageing: Longevity gains are translated into equivalent additional years in good health.
Income elasticity = 0.6 The residual growth is 1.7% in the starting period and then converges to 0 in 2060.
Income elasticity = 1 Healthy ageing: Longevity gains are translated into equivalent additional years in good health.
Income elasticity = 1
Note:
The key assumption changed in each scenario is in bold.
assumed to affect all age groups in the same proportion. In other words, while demography is not a main driver of health spending growth, it will induce a significant change in the structure of the spending.
The total effect of demographics and income on the increase in public health care expenditures by 2060 is very different across countries (Table 4) . In OECD countries, the demographic effect ranges from 0.2 percentage points of GDP in Belgium, Iceland and the United Kingdom to more than 1.8 points in Chile, Korea and Turkey. For non-OECD countries it varies from zero in South Africa to 1.7 percentage points of GDP in Brazil and China, reflecting more rapid ageing in the latter two countries.
With an assumed less-than-unitary real income elasticity, the underlying increase in income would imply ceteris paribus a decline in the health expenditure to GDP ratio. As the GDP projections embody a degree of convergence towards living standards of high-income countries, this downward income effect on spending ratios is more important for rapidly catching-up low-income countries. Indeed, on average for OECD countries, the decline in expenditure ratios due to income growth will amount to -0.8 percentage points, while in non-OECD countries it will be -1.4 percentage points.
The cost pressure scenario
As mentioned earlier, in the "cost pressure scenario", it is assumed that on top of the demographic and income effects, health expenditure will grow by a residual 1.7% per year over the whole projection period. In this scenario, the OECD average health expenditure to GDP ratio is projected to increase by more than 6 percentage points, reaching close to 12% in 2060 from a starting value of 5.5% in 2006-10. The largest increases (above 7 percentage points of GDP) are found in Chile, Korea and Turkey, while the lowest (below 6 percentage points of GDP) are found in Belgium, Denmark, Estonia, Finland, Hungary, Iceland, Sweden and the United Kingdom. Starting from a much lower ratio of health expenditure to GDP at 2.4%, the BRIICS will experience a larger increase as the ratio is set to more than triple, to reach 8.3%. The most important part of these increases is due to the residual component.
For both OECD and non-OECD countries, the increase, on average, will be slightly higher in the second part of the projections period. 
The cost-containment scenario
While the cost-pressure projections may be useful as a benchmark, they do not seem very plausible. It is unlikely that public health-care expenditures to GDP could continue to grow at such rates, without limit. For instance, regarding drugs, the following policies can help containing the costs: a more intense use of generics, a revision of reimbursement practices for drugs with low medical service (and more stringent restrictions on exemptions to this rule), a more frequent re-evaluation of prices of new drugs (in general a more transparent and dynamic pricing of new drugs), centralised bargaining for the purchase of drugs and medical goods in public hospitals, reduction in excessive consumption of specific drugs. Regarding in-patient care, shorter length of stay, development of ambulatory hospitalisation or more user choice among health providers could help reining in the expenditure growth. Regarding out-patient care, a more stringent health monitoring of patients affected by long-term diseases in order to reduce costly complications; financial incentives set on general practitioners to reduce prescription inflation and enhance prevention could also help in maintaining the health expenditure on a sustainable path.
Accordingly, a long-run convergence condition is considered in the cost-containment scenario. Specifically, the growth contribution of the spending residual, whose past growth was partly attributable to technology and relative price effects, is assumed to converge to zero in 2060, implicitly representing the assumption that policies are more effective than in the past in controlling the expenditure growth driven by non-demographic non-income related factors.
In this scenario (Table 4) 
Sensitivity analysis
In the sensitivity analysis, a number of parameters were changed in the context of the "cost-containment scenario": the income elasticity, the residual spending growth, as well as factors underlying health status at old age (Table 5) . Overall, the previous results seem relatively robust. Specifically, these alternative simulations do not change qualitatively the picture emerging from the comparison of the "cost-pressure" and "cost-containment" scenarios discussed above.
First, given that assumptions on the future evolution of the residual are necessarily arbitrary, their impact on projections was checked by computing a cost-containment scenario in line with the assumptions behind such a scenario in the previous 2006 OECD projections. In this variant (not shown in the table), on top of the demographic and income effects, the residual component is assumed to contribute 1% per year, tending towards 0% in 2060. On average, the health expenditure to GDP ratio across OECD countries reaches 6.8% instead of 7.9% in this new exercise. For non-OECD countries, the ratio will reach 3.3% instead of 4.4%. As the assumption underlying this scenario is common for all countries, the percentage point deviation from cost-containment scenario is the same for all countries (-1.1). However, the assumptions behind this scenario may be overly optimistic:
the lower value of the residual growth contribution in the 2006 exercise reflected in part a higher income elasticity which arithmetically left less of historical spending growth to be explained by the residual. Assuming both lower income elasticity than in the 2006 exercise and a similar residual spending component may be too much to hope for.
As regards the residual growth, we also tested the effect of assuming country-specific residuals. This test is equivalent to the IMF assumption (IMF, 2012) except that in our scenario the residual is assumed to converge to zero in 2060. On average, the health expenditure deviation from the base case will be 0.8 percentage points of GDP. But this moderate average change represents in fact very different evolutions across countries. This assumption would lead to rather extreme scenarios for some countries (e.g. Iceland,
Australia, Portugal, Austria, Spain and Denmark). Such large increases in the health expenditure ratios are due to country-specific conditions in the base period, which are unlikely to persist in the future.
There is considerable uncertainty concerning the income elasticity of health spending.
The sensitivity analysis is carried out taking plus and minus two standard deviations from the value estimated in the benchmark regressions, corresponding to an income elasticity equal to 0.6 and 1, respectively. When the income elasticity is set to 1, on average for OECD countries the health expenditure deviation from the base case will be 0.8 percentage points of GDP to reach 8.7%. It is slightly higher for non-OECD countries at 1.4 percentage points of GDP. In both groups of countries, those with the largest projected GDP per capita growth are obviously the most affected by changes in the income elasticity. When the income elasticity is set to 0.6, health expenditure deviates from the base case by -0.6 percentage points of GDP on average in OECD countries, to reach 7.3%. This deviation is much higher in non-OECD countries, amounting to -1 percentage point of GDP.
Sensitivity to alternative health status was also explored. In an "expansion of morbidity" scenario, the share of life spent in ill health would increase as life expectancy increases (e.g. an increase in the survival rates of sick people), while a "compression of morbidity" scenario would mean the opposite (e.g. an improvement in the health status and health behaviour of the new cohorts of old people). Under these scenarios, by 2060, average health expenditures in OECD countries range from 7.2 to 8.7% of GDP. In non-OECD countries, they range from 3.7% to 5.6%. Thus, while alternative health regimes matter for projecting future expenditure trends, their impact on projections is smaller than that of non-demographic effects.
Long-term care
Long-term care differs radically from health care. While health care services aim at changing the health condition (from unwell to well), LTC merely aims at making the current condition (unwell) more bearable. Individuals need LTC due to disability, chronic condition, trauma, or illness, which limit their ability to carry out basic self-care or personal tasks that must be performed each day. Such activities are defined as activities of daily living (ADLs), which embrace eating, dressing, bathing, getting in and out of bed, toileting and continence or instrumental activities of daily living (IADLs), which include preparing own meals, cleaning, laundry, taking medication, getting to places beyond walking distance, shopping, managing money affairs and using the telephone/internet.
A person is dependent if he or she has limitations in ADLs or IADLs.
It should be noted that LTC also includes a small part of health services that are thus not accounted for in health care. Indeed, total LTC spending is calculated as the sum of health care and social services for those in LTC (Colombo et al., 2011) . Health-related LTC spending includes palliative care, long-term nursing care, personal care services, and health services in support of family care. Social services provided for LTC include home help (e.g. domestic services) and care assistance, residential care services, and other social services. In other words, the health component of LTC spending includes episodes of care
where the main need is either medical or personal care services (ADL support), while services whose dominant feature is help with IADL are considered outside the healthspending boundaries.
A striking difference between spending on health and LTC is that the cost of LTC per beneficiary is roughly independent of age ( Figure 8) . Indeed, the cost of helping one person in ADLs or IADLs could be more or less the same, irrespective of their age. Moreover, while potentially the entire population may benefit from health care, only dependent persons will benefit from LTC. Therefore, while the age-specific cost curve for health care was expressed per capita for each age group that for LTC is expressed per dependant.
As for health care, two kinds of determinants drive LTC expenditure: demographic and non-demographic ( Figure 9 ). The demographic driver is related to the number of dependent people in the population. The evolution of this factor depends on the evolution of life expectancy and health expenditure. The non-demographic drivers are related to income developments and changes in the demand for public-financed LTC services.
Income is assumed to have a direct effect via increases in living standards (GDP per capita)
and an indirect effect via cost-disease (relative productivity or Baumol) effects. Given the importance of home production of LTC services, the demand for public spending on LTC is assumed to depend on developments in formal labour force participation. 
Projection framework
The framework used to project public LTC expenditure distinguishes between demographic and non-demographic drivers. The evolution of each driver is projected separately. They are then combined to compute the future growth of total LTC expenditure.
The basic projection equation can be interpreted as a reduced form combining demand and supply factors that determine equilibrium LTC expenditures. More details on these assumptions and the corresponding variable definitions are provided below and in Annex A. They combine a demographic effect which in the case of LTC stands for the number of dependent people; a Baumol effect captured by the labour productivity differential between the LTC sector and the rest of the economy with an elasticity that can take the value of 1 or 0.5, depending on the scenario (0.5 or 0.25 for the BRIICS); an income effect with an elasticity of LTC expenditures that can take the value of 1 or 2; and the changes in the provision of informal care proxied by the evolution of labour force participation of women aged 50-64 with an elasticity of 0.7.
The growth rates are first projected for each country. Applying the same methodology as for health care, those growth rates are then adjusted to allow for a certain convergence of LTC expenditure to GDP ratio across countries. This allows taking into account a faster catching up of countries starting from a low basis. For instance, emerging economies such as China or Indonesia which will face a fast growing ageing population and as a consequence increasing demand for LTC might introduce LTC policies.
In order to smooth out the impact of the recent crisis on expenditure, the starting point for each country is computed as the average share of public LTC spending in GDP over 2006-10. It has to be noticed that this assumption may be too conservative. Indeed, contrary to health care, spending has increased recently in countries where public LTC is provided. 8 Public LTC is expected to continue growing or to be introduced where it is not yet available.
Demographic drivers of expenditure
Whereas health care projections distinguished between survivors and non-survivors, the LTC projections split each age group into dependants and non-dependants. The agespecific dependency ratios have been estimated by the European Commission for 22 European countries (Ageing Report 2009). Even if the shape of the dependency ratios by age differs across countries, the dispersion remains relatively limited (Figure 10) . Thus, as a first approximation, dependency ratios (number of dependants by age group) are assumed to be broadly uniform across countries. For the purpose of projecting expenditure, this also has the advantage of eliminating current differences in the prevalence of dependency across countries as a possible cause for future differential increases in LTC expenditures. In other words, the projections become less sensitive to initial conditions. Noteworthy, this assumption therefore abstracts from the influence of differences in policy settings on these initial conditions.
For the calculation of the pure demographic effect, it is assumed that the LTC spending per dependant remains constant. Thus, the variation in LTC expenditure resulting from the pure demographic effect is only driven by the increase in the number of dependants by age group. The latter is derived from the average age-specific dependency ratio (see above) multiplied by the population by age group.
The number of dependent people in the population depends on the evolution of longevity and spending on health care. As the age-specific dependency ratio rises sharply after the age of 75, any increase in life expectancy above that threshold can increase significantly the number of old-age dependants, thereby putting pressure on LTC spending.
Moreover, as health care spending improves the probability of survival at old-age, it can also push up LTC spending. This will be the case, for instance, if survival at older ages translates into an increase in the prevalence of chronic diseases. However, if improvements in life expectancy at birth translate into additional years in good health, the increase in dependency occurs later in life. Therefore the initial spending pressures from higher longevity are mitigated by such healthy ageing.
In order to project the evolution of dependency until 2060, taking into account the possible link between dependency and health-care expenditures, the age-specific dependency ratios have been estimated based on historical data as a function of age, agespecific per capita health-care expenditures and life expectancy at birth (see Box 2).
Consistent with the healthy-ageing hypothesis, dependency at old age is found to decline over time. But the decline of the dependency ratio by age group depends in turn on the evolution of life expectancy at birth and per capita public health care expenditures (as projected in the cost-containment scenario for health care). Accounting for the influence of health-care expenditure on the dependency ratio generates a link between the health-care and LTC projections even though the two spending items are projected separately. Clearly, this link may materialise with a lag, which is however difficult to ascertain empirically, especially in the context of the mostly cross-section data used in this paper. Therefore, a contemporaneous link is assumed for simplicity.
Non-demographic drivers of expenditure
Apart from the evolution of the number of dependants in the population, nondemographic drivers also have an impact on LTC expenditure growth. The projections account for three of them: changes in the relative price of LTC, income effects and changes in the demand for public-financed LTC, which in turn depend on the availability of informal care.
One of the main non-demographic drivers of public LTC expenditure is the relative share of informal and formal care. 9, 10 Most informal care is provided by family and friends (Colombo et al., 2011) . Even using a narrow definition of the family care "workforce", its size is at least twice that of the formal care workforce (e.g. in Denmark), and in some cases it is estimated to be more than ten times the size of the formal-care workforce (e.g. Canada, New Zealand, the United States, the Netherlands). On average, around 70% to 90% of those who provide care are family carers (Fujisawa and Colombo, 2009) . Changing societal models -such as declining family size, changes in residential patterns of people with disabilities and rising female participation in the formal labour market -are likely to contribute to a decline in the availability of informal care-givers, leading to an increase in the need for paid care (Colombo et al., 2011) . Since there is evidence that informal elderly care is associated with lower female labour force participation (Viitanen, 2005) , informal carers have been proxied by the labour force participation of women aged 50-64 to project the future evolution of LTC spending (a sensitivity check has also been carried out using their exit rate from the labour force). As participation rates by age and gender are not readily available for non-OECD countries, informal carers have been proxied by the overall participation rates in these countries.
Another important non-demographic driver of public LTC expenditure is a "cost disease" or Baumol effect (Baumol, 1967; 1993) . The LTC sector is highly labour-intensive
Box 2. Dependency ratio estimates
In order to gauge the evolution of the dependency ratio, its past determinants have been investigated by means of panel regression techniques. Defining Depr i, a as the dependency ratio (number of dependent people for country i and age a), Age as the central point in each age bracket (2, 7, 12, …, 97) , he i, a the real public health care expenditure per capita for country i and age a and LE i life expectancy at birth for country i, the following equation was estimated:
The equation was estimated for the population aged 52 and above, as the dependency ratio for people below 52 is small and roughly constant over time. As expected, the age variable has a highly significant, positive impact (see de la Maisonneuve and Oliveira Martins, 2013) . Public health expenditure per capita also has a significant positive effect, though much smaller. Conversely, increased life expectancy at birth delays the prevalence of dependency.
Including life expectancy at birth minimises the possibility that this effect could be driven by health expenditures themselves, thereby avoiding multicollinearity problems between health expenditure and life expectancy.
and the room for productivity gains is often seen as more limited than elsewhere in the economy. With equalisation of wages across sectors, this implies that the relative price of LTC vis-à-vis other goods and services in the economy, tends to rise as aggregate productivity and GDP per capita increase. With a price-inelastic demand, the share of LTC expenditure in GDP would, therefore, tend to increase over time. A possible way to capture this effect is to assume that unit costs rise in line with average earnings of care staff or a measure of wage inflation in the economy (Comas-Herrera et al., 2003) . In this paper, productivity growth in the total economy has been used as a proxy for the Baumol effect on public LTC expenditures. 11 Finally, income is also likely to play a role in LTC expenditure. Indeed, as real incomes rise, demand may be directed at higher quality services (Colombo et al., 2011) , thereby increasing expenditures. Figure 11 shows a positive relationship between income and public LTC expenditure with an elasticity above one. It is difficult however to distinguish the income from the cost-disease effect, proxied by aggregate productivity, since they are too highly correlated. Given the multicollinearity between productivity and income, the two effects were estimated separately. The estimated influence of each of the nondemographic drivers of LTC expenditures has been used to parameterise the projection equation in Box 3. 
Projection results: Long-term care, 2010-60
As for health care, a cost-pressure scenario and a cost-containment scenario were computed. Both scenarios are based on a unitary income elasticity assumption and the "healthy ageing" hypothesis. However, in the cost-pressure scenario, for OECD countries, a full Baumol effect is assumed, meaning that LTC unit labour costs increase fully in line with aggregate labour productivity; for non-OECD countries, excess labour supply especially in the non-tradeable sector suggests weaker wage pressures than in the OECD countries, and therefore the cost-pressure scenario only incorporates half of the Baumol effect. In the cost-containment scenario, the elasticity of LTC spending to productivity increases is set at half the value of the cost-pressure scenario (0.5 for OECD countries and 0.25 for non-OECD countries), possibly reflecting policy action aimed at mitigating relative wage increases of LTC providers. For example, action to curb expenditure could be aimed at facilitating access to LTC provision by low-skilled migrants or at providing incentives to balance institutional and home-based LTC.
Sensitivity analysis has been carried out in the context of the cost-containment scenario, with respect to the Baumol effect, the income elasticity and the implications of healthy ageing for the number of dependants. As for health care, the starting year of the projections is an average over the period 2006-10 so as to smooth out the impact of the recent crisis. The main assumptions underlying each projection scenario are listed in Table 6 .
As with projections of public health-care spending, non-demographic drivers account for the lion's share of future expenditure increases (Table 7) , although with an assumed
Box 3. Estimations to calibrate the LTC framework
In order to estimate the LTC spending elasticities to productivity (Baumol effect) and to the participation rate, which are used to parameterise the projections model, the following equation was estimated over the period 1990-2009: where the share of long-term care expenditure in GDP [LTC/(P y *Y)] is explained by Prod, the total economy productivity capturing the Baumol effect (or alternatively the income per capita variable to estimate the income elasticity) and PR, the female labour force participation rate used as a proxy for the provision of informal care (or alternatively their exit rate from employment was also used). In this equation OAdep, the ratio of people aged 80 and above to total population, is a control variable that plays no role in the projections, as a demographic effect already covers the effects of ageing.
As expected, the old age dependency ratio (people above 80) is a significant determinant of LTC expenditure (see de la Maisonneuve and Oliveira Martins, 2013). The relative price effect (proxied by total economy productivity) emerges with an elasticity of around 2. Alternatively, when the income variable is introduced, its elasticity amounts to around 2.7. While regression estimates point to Baumol or Income elasticities higher than unity, a conservative choice has been made of a unitary elasticity for both the relative price and the income variable. Sensitivity analysis has been carried out to test for the impact of these assumptions with the income elasticity alternatively fixed at two (see below). Finally all the proxies for informal care (female participation or exit rate from the labour force) also turned out to be significant.
elasticity of unity, the income effect is not creating additional pressures in terms of expenditure shares to GDP. Demographic changes are projected to exert a relatively minor influence on future public LTC expenditures. Indeed, as the LTC cost is independent of age, the pure age effect has only a moderate impact on spending except where ageing is fast enough to increase significantly the share of very-old people in the population (e.g. Korea,
China, Indonesia). Moreover, this effect is mitigated by the "healthy ageing" assumption.
The cost-pressure scenario
In the cost-pressure scenario, starting from 0.8% of GDP on average for OECD countries, the ratio of public LTC expenditure to GDP is projected to increase by 1.4 percentage points to reach 2.1% of GDP. However, some countries, like Chile, Estonia, Korea, Mexico and Turkey, will experience higher increases (equal to or above 2 percentage points). These countries are n.a. n.a. n.a.
Cost-pressure scenario Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy and health expenditure (cost-containment scenario).
Income elasticity = 1 OECD countries: Full Baumol effect (elasticity = 1).
OECD countries: Baseline scenario for participation rates of women aged 50-64.
BRIICS: Half Baumol effect. BRIICS: Total participation rates.
Cost-containment scenario Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy and health expenditure (cost-containment scenario).
Income elasticity = 1 OECD countries: Half Baumol effect (elasticity = 0.5).
BRIICS: 1/4 of Baumol effect. BRIICS: Total participation rates
Sensitivity analysis based on the cost-containment scenario
Income elasticity = 2 Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy and health expenditure.
Income elasticity = 2 OECD countries: Half Baumol effect (elasticity = 0.5).
BRIICS: 1/4 of Baumol effect. BRIICS: Total participation rates.
Life expectancy plus 2 standard deviation
Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy plus 2 standard deviation and health expenditure.
Life expectancy minus 2 standard deviation
Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy minus 2 standard deviation and health expenditure.
Cost-pressure health scenario Healthy ageing: The prevalence of dependency per age is shifted according to the evolution of life expectancy and health expenditure (cost pressure scenario).
Note:
The key assumption changed in each scenario is in bold. starting from a very low level of LTC expenditure and are in the process of catching up to higher levels. Conversely, Israel, Luxembourg, Sweden, the United Kingdom and the United States are projected to experience only small increases in their LTC expenditure to GDP ratios (less than 1 percentage point). Differences in the initial level of female participation rates as well as policies in place also explain the differences across countries. For non-OECD countries, the increase in LTC spending is projected to be, on average, broadly the same as that experienced by OECD countries but starting from a much lower level (0.1%).
The cost-containment scenario
In the cost-containment scenario, on average for OECD countries, the public LTC expenditure to GDP ratio increases by 0.8 percentage point from 0.8% to 1.6% of GDP. Chile, Korea, Mexico and Turkey experience the most important increases (above 1.3 percentage points), while the increase in Finland, Iceland, Norway, Sweden, the United Kingdom and the United States does not exceed 0.5 percentage points. Non-OECD countries will experience on average the same increase as OECD countries (0.8 percentage points).
Sensitivity analysis
Given the uncertainty about income effects, projections were performed also assuming an income elasticity of 2 for the cost-containment scenario for OECD countries.
For non-OECD countries, the sensitivity analysis assumed an income elasticity of 1.5. On average, for OECD countries LTC expenditure would reach in this case 2.5% of GDP in 2060.
In this scenario, Chile, Estonia, Mexico and Turkey would experience a deviation from base case of around 1.7 percentage points of GDP. Again, the assumptions underlying the GDP projections assume some catch-up for these low income countries, explaining why their LTC expenditure patterns are more affected by the higher income elasticity assumption.
For non-OECD countries, the share of LTC in GDP would reach 1.8% of GDP with the higher income elasticity. China, India and Indonesia would experience a deviation from the base case of more than 1 percentage point (see Table 8 ).
A sensitivity analysis has also been carried out for the evolution of the number of 
Prospects for total public spending on health
Both health and LTC expenditures are projected to put sizeable pressure on public finance over the next 50 years. Overall, on average across OECD countries, the total health and LTC expenditure to GDP ratio is projected to more than double in the cost-pressure scenario, increasing from 6.2% in the starting period to 13.9% of GDP in 2060. In the costcontainment scenario the ratio would still increase by more than half, to reach 9.5%
( Figure 12 ). For the BRIICS, starting from a much lower level, public health and LTC expenditure will increase from 2.5% in the starting period to about 10% and above 5%
in 2060 in the cost-pressure and the cost-containment scenarios, respectively.
There are, however, striking differences across countries ( Figure 13 ). In the costcontainment scenario, one group of countries experiences a 4 to 5 percentage point increase in total spending to GDP ratios over the period 2010-60. It includes countries that are ageing very rapidly (Korea and Chile), as well as those with currently low labour force participation especially of women, which may face a substantial increase in the demand for formal long-term care (Spain and Mexico) as labour force participation increases and care is no longer provided by family. By contrast, in the United States, the United Kingdom and the Nordic countries the projected increase is below 3 percentage points of GDP. In these countries demographic trends will be more stable and the share of formal long-term care is already relatively high. On average, spending ratios in the BRIICS will remain lower than in OECD countries. However, they will rise significantly under both scenarios. For instance, even in the cost-containment scenario, ratios will more than double by 2060 -close to levels currently observed in OECD countries (Table 9 ).
These new projections broadly deliver the same message as those in Oliveira Martins and de la Maisonneuve (2006); even in the cost-containment scenario, public health care
and LTC spending will put an important burden on future public finances. The new set of S l o v a k R e p u b l i c S l o v e n i a C h i n a P o l a n d G r e e c e P o r t u g a l I t a l y S w i t z e r l a n d O E C D a v e r a g e I n d o n e s i a N e t h e r l a n d s J a p a n A u s t r a l i a I r e l a n d I s r a e l C a n a d a N e w Z e a l a n d A u s t r i a C z e c h R e p u b l i c G e r m a n y E s t o n i a H u n g a r y
N o n -O E C D
a v e r a g e N o r w a y F r a n c e B e l g i u m U n i t e d S t a t e s D e n m a r k F i n l a n d U n i t e d K i n g d o m I c e l a n d I n d i a S w e d e n R u s s i a n F e d e r a t i o n S o u t h A f r i c a projections suggests a more important increase in health care expenditure, both in the cost-pressure and the cost-containment scenarios while, regarding public LTC funding, the increase in expenditure is lower in the new set of projections than in the previous one. Overall, on average, the current projections suggest only a slightly lower increase in total health and LTC expenditure confirming the message delivered by the previous set of projections. A comparison between these new projections and the ones from the European Commission, the IMF and the Congressional Budget Office in the United States suggests that the differences arise mainly as a consequence of varying assumptions concerning the future evolution of the main drivers of spending (see de la Maisonneuve and Oliveira Martins, 2013 for details). The EC projected increases in health-care expenditure are the lowest due to the nearly unitary income elasticity associated with the absence of a residual growth. The IMF projections, although difficult to compare as they end in 2050, seem to range between the OECD cost-containment and cost-pressure scenarios. The assumption of low income elasticity is broadly offset by the country specific residual. Nonetheless when the estimated residual is higher than the average like in the United States, the projected increase in health care expenditure is much higher. This high increase is corroborated by the CBO projections.
Concluding remarks
Long-term spending projections are inherently uncertain and subject to upside or downside risks. While a more moderate evolution of spending than in these projections cannot be excluded (for instance if cost-saving technologies were to spread out, or if more aggressive cost-containment policies were to be implemented), there are also clear upside risks on spending. For instance, higher health spending could arise due to an extension of the pre-death period of ill health as longevity increases, or because of higher than expected costs induced by technical progress. Regarding LTC, higher spending could arise from increased dependency due to obesity trends or dementia. Indeed, according to recent calculations, some 12% of those aged between 80 and 84 years, and almost one in four of those aged over 85 years, suffer from dementia (Alzheimer Europe, 2006) . With ageing populations, strong increases in the prevalence of dementia may be expected (see Box 1.1
in Colombo et al., 2011) , though prevention and treatment may also improve in the future.
Even if these upside risks do not materialise, the spending projections point to important policy challenges. These challenges are reinforced by the evidence that macroeconomic cost-containment policies, which had some success in repressing spending trends over the 1980s and 1990s, have their limits. For instance, it is difficult to contain wages and at the same time, attract young and skilled workers into the health-care system. Similarly, controlling prices is not easy when technical progress is permanently creating new products and treatments, while overall constraints on supply result in unpopular waiting lists for these treatments. More generally, it is difficult to determine the appropriate supply of health and LTC services without market signals -but at the same time, health and LTC are areas where market failure is rife.
Notes
1. To focus on the structural factors and eliminate cyclical effects, the ratio is computed using trend instead of actual GDP (from the OECD Economic Outlook, No. 91).
2. Tax expenditure can be of different kinds, e.g. exclusion from workers' taxable income of employers' health insurance contributions in the United States, tax credits for medical expenses in Canada or income tax deductions for health care services in Portugal.
3. For more details, see Johansson et al. (2012) .
4. While the probability of dying increases with age, the costs of death tend to decline steadily after young and prime age (Aprile, 2004) . Other estimates of DRC are coherent with this order of magnitude (e.g. Yang et al., 2003) .
5. See, for example Fuchs (1984) ; Zweifel et al. (1999); Jacobzone (2003); .
6. While he/N and Y/N are found to be I (1) and co-integrated, the complete VECM with all explanatory variables did not provide good results. Thus a regression on growth rates addresses the problem of a possible spurious correlation between the two variables. The results presented in the last column of Table 2 confirm the level estimates.
7. It has to be noted that depending on the type of expenditure this upward shift may be nonhomothetic across ages. For example, expenditure at older ages may be more affected by such an upward shift than at younger ones.
8. For instance, Korea introduced the public LTC insurance in 2008 and it has increased since then. The same occurred in Estonia, Japan and Portugal.
9. Formal care is provided by care assistants who are paid for providing care under some form of employment contract. It includes both care provided in institutions and care provided at home. To be considered informal, the provision of care cannot be paid for as if purchasing a service. However, an informal care-giver may still receive social transfers conditional on his/her provision of informal care and possibly, in practice, some informal payment from the person receiving care.
10. The projections do not distinguish between formal care delivered within institutions and that delivered to the patient's home. There are fundamental differences between countries in the way they organise their formal LTC. Institutional LTC is particularly widespread in the Nordic countries (OECD, 2005) . Whether this form of organisation is adopted by other countries or a (cheaper) ambulatory help-at-home strategy is pursued could have important consequences for public expenditures.
ANNEX A
Data sources and method
Health and LTC data
Health and LTC expenditures
The historical public current health and LTC expenditure to GDP ratios come from the OECD Health Database (2011) that provides comparable health statistics across OECD countries. Total public current expenditure on health is the sum of total personal and total collective services but excludes investment. The LTC spending corresponds to the "Services of long-term nursing care" item. The latter is subtracted from the Total public current expenditure to get the health spending.
Total expenditure on health is defined as the sum of expenditure on activities that -through application of medical, paramedical, and nursing knowledge and technologyare aimed at: promoting health and preventing disease; curing illness and reducing premature mortality; caring for persons affected by chronic illness who require nursing care; caring for persons with health-related impairments, disability, and handicaps who require nursing care; assisting patients to die with dignity; providing and administering public health; providing and administering health programmes, health insurance and other funding arrangements. Public expenditure on health care is health expenditure incurred by public funds. Public funds are state, regional and local Government bodies and social security schemes.
Long-term health care comprises ongoing health and nursing care given to in-patients who need assistance on a continuing basis due to chronic impairments and a reduced degree of independence in activities of daily living. In-patient long-term care is provided in institutions or community facilities. Long-term care is typically a mix of medical (including nursing care) and social services. An average expenditure curve for survivors was estimated econometrically in a panel of 23 countries and 20 age groups, using a spline function as follows:
Cost curves by age groups
where he is the real health expenditure by age group, N population by age group and age is the central point in each bracket (e.g. 2, 7, 12, …, 97).
For each country, this expenditure curve by age group is multiplied by country-specific population by age group in order to obtain a total country-specific health expenditure. This expenditure is then calibrated to fit with the OECD database total expenditure in the base year.
LTC Dependency ratios
The dependency ratios (number of dependants by age group) were derived from the European Commission 2009 Ageing Report. Even if the shape of the dependency ratios by age differs across countries, the dispersion remains relatively limited ( Figure 10 in the main text). Accordingly, dependency ratios are assumed to be broadly uniform across countries and an average dependency ratio by age group was calculated and used in the projections. The dependency ratios are then projected using the evolution of life expectancy at birth and health expenditure (cost-containment scenario). The life expectancies at birth are those underlying official population projections. 
Macro data
GDP
Health prices and technology
The health price measure used in this paper is the value-added deflator in the health and social work sectors, taken from the OECD STAN Database. Even if this measure may not be as accurate as needed, it is nonetheless more comparable across countries than more precise price indicators available from other sources. For instance, CPI series for the health sector can be gathered from Eurostat (for European countries) and national sources (for Australia, Canada, Korea, New Zealand and the United States). The CPI series cannot, however, be used because they are available for too short a period (the HICP from Eurostat is only available from 1996 onwards) and there is also a potential lack of comparability across countries.
The quality effect combines an indicator of patents with an indicator of R&D statistics.
The patents granted by the European Patent Office (EPO) have been chosen as they seem to generate substantially greater market power than their US equivalents (Bessen, 2013) (Okunade and Murthy, 2002) ; moreover, high R&D spending is needed to enable the adoption of foreign technologies (the so-called absorption potential). Hence, the ratio of total R&D expenditure to GDP has been used as a proxy for the ability of a country to reach the frontier. The data come from the OECD R&D database.
Baumol effect
The "cost-disease" Baumol effect is proxied by the productivity growth in total economy. The productivity data come from the OECD Economic Outlook, No. 91, and Johansson et al. (2012) . It is calculated as real GDP per worker in 2005 constant PPP USD.
Participation rate
Participation rates are those underlying GDP projections and come from the OECD Economic Outlook, No. 91, and Johansson et al. (2012) . For OECD countries, the participation rate projections are based on the so-called "cohort approach" (Burniaux et al., 2003) . The cohort approach assumes that the observed participation behaviour of individuals belonging to the most recent cohorts, such as the lower exit rates of current old-age workers relative to previous cohorts, or the higher entry rates of current young women relative to previous cohorts, will continue to apply to future cohorts as well. Therefore, future participation rates are determined by the participation behaviour of the most recent cohorts and the evolution of the relative weight of different cohorts, which is driven by demographic developments (see Johansson et al., 2012 , for more details).
Some policy reforms are taken into account in the labour force participation projections.
First, the long-term trend expansion in education -and the associated increase in average years of schooling -is assumed to continue in all countries. Second, longer life expectancy and health improvements raise the scope for policies that encourage higher labour market participation at older age. And finally, a number of countries have already implemented or plan to implement reforms aiming to extend working lives, including by increasing the legal age to get a full pension. Recently-legislated pension reforms that involve an increase in the normal retirement age by 2020 are assumed to be implemented as planned* (see Johansson et al., 2012 , for more details).
